ACTSI
Atlanta Clinical & Translational Science Institute
Emory Morehouse School of MedicineGeorgia Tech

Funded by: NIH | NCATS | CTSA

Rotating Image

eRoundup for 05/04/12

Atlanta Clinical & Translational
Science Institute
Weekly eRoundup
May 4, 2012

Funding Opportunities

Community-Based Participatory Research Initiative in Reducing & Eliminating Health Disparities: Planning Phase (R24)-LOI Due May 27

The National Institute on Minority Health and Health Disparities is interested in supporting applications that propose to develop and strengthen partnerships between health disparity communities and researchers to plan the implementation of effective health interventions that will improve community health and reduce health disparities.

Read more...

Translational Research to Improve Obesity & Diabetes Outcomes (R18)-Due July 2

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) encourages NIH Research Demonstration and Dissemination Project grant (R18) applications from institutions to test practical, sustainable, acceptable and cost efficient adaptations of efficacious strategies or approaches that prevent and treat diabetes and/or obesity. Planning Grant

Read more...

Research Resources

iResearchGeorgia Profile

Dr. Gang Bao

Read more...

Georgia Cancer Online Resource

www.GeorgiaCancerInfo.org is now live. This unique, new comprehensive online cancer information center is the first of its kind and contains the latest information on oncologists, cancer centers, clinical trials and cancer resources in the state of Georgia.

Read more...

NIH Launches Collaborative Program with Industry & Researchers to Spur Therapeutic Development

The NIH unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients. NIH's National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly and Company which have agreed to make dozens of their compounds available for this initiative's pilot phase.

Read more...

Studies of Biomolecular Interactions by Biacore T200 at GA Tech

The Biacore T200 at Institute of Electronics and Nanotechnology (IEN) at GA Tech can be used for detailed studies of biomolecular interactions, from early research to drug discovery and development, and on to QC.

Read more...

Educational Opportunities

FDA-Commissioner's Fellowship Program-Due May 25

The FDA offers a two-year Fellowship Program, which provides an opportunity for health professionals and scientists to receive training and experience at the FDA.

Read more...

New Visiting Scholars Program at Frederick National Laboratory

The Visiting Scholars Program is an opportunity to access the resources available at the Frederick National Laboratory for Cancer Research. Visiting Scholars will be integrated with teams of scientists who investigate the biological mechanisms of cancer and AIDS, conduct translational research leading to new diagnostic and therapeutic approaches and advance preclinical studies leading to first-in-human clinical trials.

Read more...

New Course on Pharmaceutical Development: From Drug Lead to Drug Product

New, interdisciplinary short‐course for doctoral students engaged in pharmaceutical research offered at GA Tech.

Read more...

Events

Research Residency Program-May 25 and June 1

The ACTSI’s Clinical Interaction Network’s three day Research Residency Program is designed to provide novice and experienced nurses with the knowledge and skills that will aid their navigation through the clinical research process. The areas of focus are research design and methodology, ethics, research subject’s rights and safety, critical thinking, clinical practice, evaluation of clinical data and application of patho-physiological and psychosocial concepts within the multidisciplinary team.

Read more...

Jean Sindab Triple Negative Breast Cancer Symposium-May 11

The event presents current advances in triple-negative breast cancers (TNBC) by nationally recognized speakers. It increases awareness of TNBC and focuses on current, ongoing research to improve outcomes for patients. The Winship Cancer Institute of Emory University hosts the CME symposium at the Atlanta Marriott Buckhead Conference Center.

Read more...

NanoFANS Forum on Nanotoxicology-Tuesday

The 2012 Spring NanoFANS (Focusing on Advanced Nanobio Systems) Forum will begin at 11:00 a.m. at the Nanotechnology Research Center, Marcus Nanotechnology Building, GA Tech. Speakers will include Dr. Yongsheng Chen (School of Civil and Environmental Engineering, GA Tech), Dr. Stephan Klaine (School of Biological Sciences, Clemson University) and Dr. Dong Qin (School of Materials Science Engineering, GA Tech). After the talks, a tour of the Institute for Electronics and Nanotechnology Cleanroom will be offered.

Read more...

Emory Center for Injury Control Translational Research Workshop-Thursday

The workshop will be led by Dr. James Emshoff and begin at 9:00 a.m. in Emory’s Faculty Office Building, Room 101 (49 Jesse Hill Jr. Drive SE). It will be an interactive learning opportunity that will help participants better understand how to apply implementation and dissemination research to their work, including creating research questions that are truly translational in nature.

Read more...

Emory School of Medicine Postdoctoral Fellow Research Symposium-May 31

The symposium begins at 9:00 a.m. and features plenary speaker, Harriet Robinson, PhD, professor and director of microbiology and immunology at the Yerkes National Primate Research Center.

Read more...

2012 Biomedical Engineering Society Annual Meeting-October 24-27

Presented by the GA Tech-Emory Department of Biomedical Engineering and sponsored by the ACTSI. Integrating academics, industry and translation – from discovery to implementation will be the theme and will be complemented with several plenary sessions, symposiums and a career fair. The event will be held at the Georgia World Congress.

Read more...

News

ACTSI Investigator Dr. Allan Kirk in the News

Allan Kirk, MD, ACTSI investigator, professor of surgery at Emory University School of Medicine, scientific director of Emory Transplant Center and the editor-in-chief of The American Journal of Transplantation

Emory Health Now | Emory transplant roundup
March 29, 2012

Associated Press via ABC News | The Charleston Gazette | Denver Post| Maine girl bouncing back after 6-organ transplant
February 2, 2012

Atlanta Business Chronicle | Telemedicine good for transplant follow-up
July 15, 2011

Read more...

Science Advance: Spike-Timing Precision and Neuronal Synchrony Are Enhanced by an Interaction between Synaptic Inhibition and Membrane Oscillations in the Amygdala

ACTSI investigator, David Ehrlich’s work was supported by the ACTSI’s Biostatistics, Epidemiology & Research Design (BERD) program.

Read more...

Emory/Georgia Tech Healthcare Innovation Program, the ACTSI & Children's Healthcare of Atlanta Announce Recipients of the Healthcare Innovation Seed Grants

Read more...


For more information on ACTSI, please visit www.actsi.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to actsi@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email actsi@emory.edu.
 
Please include the following citation in any publications resulting from direct or indirect ACTSI support, "Supported in part by PHS Grant (UL1 RR025008, KL2 RR025009 or TL1 RR025010) from the Clinical and Translational Science Award program, National Institutes of Health, National Center for Research Resources."